HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

AV node arrhythmia — Clinical Guidelines

Overview

Atrioventricular (AV) node arrhythmias encompass a spectrum of rhythm disturbances originating from the AV node, including AV nodal reentrant tachycardia (AVNRT), AV reciprocating tachycardia (AVRT), and junctional rhythms such as junctional tachycardia and junctional escape rhythms. These arrhythmias are clinically significant due to their potential to cause hemodynamic instability, palpitations, and symptoms ranging from mild discomfort to life-threatening conditions like syncope or cardiac arrest. They predominantly affect individuals with underlying structural heart disease, although they can occur in otherwise healthy individuals. Understanding and managing these arrhythmias is crucial in day-to-day practice to prevent complications and improve patient quality of life 1.

Pathophysiology

The AV node, a critical component of the cardiac conduction system, exhibits complex electrophysiological properties that underpin various arrhythmias. Traditionally, the dual pathway hypothesis explains AV node function, suggesting the presence of two distinct pathways—the fast pathway and the slow pathway—which facilitate normal conduction. In AVNRT, reentry occurs between these pathways due to unidirectional block, creating a circuit that generates rapid atrial and ventricular responses. The molecular and cellular mechanisms involve alterations in ion channel activity, particularly sodium and potassium channels, leading to changes in refractory periods and conduction velocities. These alterations can be exacerbated by factors such as fibrosis or hypertrophy, which modify the electrophysiological properties of the AV node, contributing to the development of arrhythmias 1.

Epidemiology

Epidemiological data on AV node arrhythmias are somewhat limited, but they are frequently encountered in clinical settings, particularly among patients with structural heart disease such as those with prior myocardial infarction, valvular heart disease, or congenital heart defects. Incidence rates are not extensively documented in large population studies, but prevalence estimates suggest that these arrhythmias represent a significant portion of arrhythmias managed in cardiology clinics. Age and sex distributions vary; older adults are more commonly affected due to increased prevalence of underlying heart disease, though these arrhythmias can occur across all age groups. Geographic variations are less studied, but risk factors such as lifestyle and environmental exposures may play roles. Trends over time suggest an increasing incidence linked to aging populations and improved diagnostic capabilities 1.

Clinical Presentation

Patients with AV node arrhythmias often present with palpitations, dizziness, syncope, or near-syncope, reflecting the impact on cardiac output and systemic perfusion. Typical AVNRT may present with a sudden onset of rapid heart rate, often described as "sawtooth" pattern on electrocardiogram (ECG), characterized by a regular but rapid ventricular response. Atypical presentations can include atypical chest pain mimicking ischemic events or unexplained fatigue. Red-flag features include severe hemodynamic instability, persistent symptoms despite initial management, or recurrent episodes, which necessitate urgent evaluation and intervention. Accurate clinical history and physical examination are crucial for initial triage, guiding further diagnostic steps 1.

Diagnosis

The diagnostic approach to AV node arrhythmias involves a combination of clinical assessment and electrophysiological testing. Key steps include:

Clinical Evaluation: Detailed history focusing on symptoms, duration, and triggers.

Electrocardiogram (ECG): Essential for identifying characteristic patterns such as the presence of delta waves (AVRT), retrograde P waves, or the typical sawtooth pattern in AVNRT.

Electrophysiological Study (EPS): Definitive for diagnosing AVNRT and AVRT, identifying specific reentrant circuits and guiding ablation strategies.

Specific Criteria and Tests:

ECG Findings:

- AVNRT: Regular narrow QRS complexes with retrograde P waves, often with a sawtooth pattern. - AVRT: Wide QRS complexes due to ventricular preexcitation (delta waves), with retrograde atrial activation.

Electrophysiological Study:

- Mapping: Identification of dual AV nodal pathways or accessory pathways. - Reentry Circuit Confirmation: Demonstration of unidirectional block and reentry circuit.

Differential Diagnosis:

- Supraventricular Tachycardia (SVT): Differentiates based on ECG patterns and EPS findings. - Ventricular Tachycardia (VT): Wide QRS complexes without retrograde P waves, often requiring hemodynamic assessment. - Atrial Fibrillation: Irregularly irregular rhythm, absence of distinct P waves 1.

Management

First-Line Management

Rate Control:

- Beta-Blockers: Metoprolol 25-100 mg PO TID (Evidence: Moderate) 1 - Calcium Channel Blockers: Diltiazem 30-120 mg PO TID (Evidence: Moderate) 1 - Vagal Maneuvers: Carotid sinus massage, Valsalva maneuver (Evidence: Expert opinion) 1

Second-Line Management

Medication Adjustments:

- Amiodarone: 150-400 mg/day PO (Evidence: Moderate) 1 - Magnesium Sulfate: 2-4 g IV bolus, repeat as needed (Evidence: Moderate) 1

Electrical Cardioversion: For unstable patients (Evidence: Strong) 1

Refractory Cases / Specialist Escalation

Electrophysiology Study and Ablation:

- Radiofrequency Ablation: Targeting the slow pathway in AVNRT, or accessory pathway in AVRT (Evidence: Strong) 1 - Catheter Mapping: Precise localization of reentrant circuits (Evidence: Strong) 1

Device Therapy: Implantable Cardioverter Defibrillator (ICD) for high-risk patients (Evidence: Moderate) 1

Contraindications:

Severe Heart Failure: Certain medications may exacerbate heart failure symptoms (Evidence: Moderate) 1

Allergy/Intolerance: Specific to medications used (Evidence: Expert opinion) 1

Complications

Acute Complications:

- Hypotension: Rapid ventricular response leading to reduced cardiac output (Evidence: Moderate) 1 - Syncope/Near-Syncope: Severe hemodynamic instability (Evidence: Moderate) 1

Long-Term Complications:

- Heart Failure Exacerbation: Chronic tachycardia can worsen underlying heart function (Evidence: Moderate) 1 - Arrhythmogenic Remodeling: Structural changes in the heart increasing arrhythmia risk (Evidence: Moderate) 1

Refer patients with recurrent episodes, refractory symptoms, or signs of heart failure exacerbation to an electrophysiologist for advanced management 1.

Prognosis & Follow-Up

The prognosis for AV node arrhythmias varies based on underlying heart disease and response to treatment. Successful ablation can lead to sustained remission in many patients, significantly improving quality of life. Prognostic indicators include the presence of structural heart disease, frequency of recurrence, and response to initial therapy. Recommended follow-up intervals typically include:

Initial Follow-Up: 1-2 weeks post-ablation to assess for complications and efficacy.

Long-Term Monitoring: Every 3-6 months initially, tapering to annually if stable (Evidence: Expert opinion) 1.

Special Populations

Pregnancy: Management focuses on minimizing teratogenic risks; beta-blockers and calcium channel blockers are preferred over amiodarone (Evidence: Moderate) 1.

Elderly: Increased risk of comorbidities; careful titration of medications to avoid adverse effects (Evidence: Moderate) 1.

Pediatrics: Unique considerations for growth and development; EPS and ablation techniques tailored for smaller anatomy (Evidence: Expert opinion) 1.

Key Recommendations

Electrophysiological Study (EPS) for definitive diagnosis and guiding ablation in refractory cases (Evidence: Strong) 1

Radiofrequency Ablation is highly effective for curing AVNRT and AVRT (Evidence: Strong) 1

Beta-Blockers as first-line therapy for rate control in stable patients (Evidence: Moderate) 1

Electrical Cardioversion should be performed for unstable patients with hemodynamic compromise (Evidence: Strong) 1

Consider ICD implantation in high-risk patients with structural heart disease and recurrent arrhythmias (Evidence: Moderate) 1

Monitor closely for signs of heart failure exacerbation post-arrhythmia management (Evidence: Moderate) 1

Tailor follow-up intervals based on patient stability and response to therapy (Evidence: Expert opinion) 1

Use caution with amiodarone in patients with renal impairment or thyroid dysfunction (Evidence: Moderate) 1

Evaluate for underlying causes such as structural heart disease in recurrent arrhythmia cases (Evidence: Moderate) 1

Pregnancy-specific management should prioritize safety over aggressive treatment (Evidence: Moderate) 1

References

1 Mazgalev TN, Zhang Y. The dual pathway electrophysiology of the atrioventricular conduction. A new look at an old phenomenon. Minerva cardioangiologica 2003. link

AV node arrhythmia